The Food and Drug Administration (FDA) has submitted draft CBD enforcement guidance to the White House Office of Management and Budget (OMB) for review. The contents or even basic scope of the document—titled, “Cannabidiol Enforcement Policy; Draft Guidance for Industry”—are not yet publicly known. The agency was mandated under appropriations legislation passed late last year … Continue reading FDA Submits New CBD Enforcement Guidance To White House For Review